Evidence suggests that levels of plasma Aβ40, Aβ42, total tau, phosphorylated tau, and cystatin C, in association with the development of neuropathology in AD brain, are well-established and internationally validated plasma biomarkers in AD [30–33]. Here, MAPT is linked to Alzheimer disease.